These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 36622166)

  • 1. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells.
    Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J
    Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.
    Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD; Lee HL; Peng CW
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
    Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
    J Virol; 2020 May; 94(10):. PubMed ID: 32132242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells.
    Zhang J; Sommermann T; Li X; Gieselmann L; de la Rosa K; Stecklum M; Klein F; Kocks C; Rajewsky K
    Front Immunol; 2023; 14():1331730. PubMed ID: 38169736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.
    Münz C; Bickham KL; Subklewe M; Tsang ML; Chahroudi A; Kurilla MG; Zhang D; O'Donnell M; Steinman RM
    J Exp Med; 2000 May; 191(10):1649-60. PubMed ID: 10811859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
    Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
    Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
    Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
    Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
    J Virol; 2018 May; 92(9):. PubMed ID: 29467311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
    Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
    Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.
    Westhoff Smith D; Sugden B
    Viruses; 2013 Jan; 5(1):226-40. PubMed ID: 23325328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBNA1.
    Frappier L
    Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.
    Murakami M; Lan K; Subramanian C; Robertson ES
    J Virol; 2005 Feb; 79(3):1559-68. PubMed ID: 15650182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus.
    Saha A; Robertson ES
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30971472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.